These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8585112)

  • 1. Parallel blood concentrations of second-generation cyclosporine metabolites and bilirubin in liver graft recipients.
    Christians U; Kohlhaw K; Sürig T; Bader A; Schottmann R; Linck A; Ringe B; Sewing KF
    Ther Drug Monit; 1995 Oct; 17(5):487-98. PubMed ID: 8585112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of AM19 and other cyclosporine metabolites in the blood of liver transplant patients with stable liver function.
    Liu WT; Levy GA; Wong PY
    Ther Drug Monit; 1995 Oct; 17(5):479-86. PubMed ID: 8585111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine blood concentrations determined by specific versus nonspecific assay methods.
    Blyden GT; Franklin C; Cho SI; Kaplan MM; Hirsch CA; Greenblatt DJ
    J Clin Pharmacol; 1986; 26(5):367-71. PubMed ID: 3517079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine blood levels--an evaluation of radioimmunoassay with selective monoclonal or polyclonal antibodies and high-performance liquid chromatography in liver transplant recipients.
    Tredger JM; Steward CM; Williams R
    Transplantation; 1988 Nov; 46(5):681-6. PubMed ID: 3057689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy.
    Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH
    Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative cyclosporine metabolic pathways and toxicity.
    Christians U; Sewing KF
    Clin Biochem; 1995 Dec; 28(6):547-59. PubMed ID: 8595701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine A nephrotoxicity in liver graft recipients: determination of nephrotoxic cyclosporine blood concentrations in liver graft recipients as defined by the HPLC and RIA tests.
    Hamilton G; Mühlbacher F; Roth E; Steininger R; Wolf I; Schindler J; Wolosczuk W; Piza F
    Transplant Proc; 1987 Oct; 19(5):4045-8. PubMed ID: 3313996
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
    Schroeder TJ; Brunson ME; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DI; Weibel ML; Wadih G; First MR
    Transplantation; 1989 Feb; 47(2):262-6. PubMed ID: 2645710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of cyclosporine and its metabolites in blood via HPLC-MS and correlation to clinically important parameters.
    Vollenbroeker B; Koch JH; Fobker M; Suwelack B; Hohage H; Müller U
    Transplant Proc; 2005 May; 37(4):1741-4. PubMed ID: 15919451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine and bilirubin metabolites compete for the hepatic excretory system.
    Kohlhaw K; Christians U; Sürig T; Lamesch P; Hauss J; Sewing KF; Pichlmayr R
    Transplant Proc; 1994 Oct; 26(5):2798-9. PubMed ID: 7940880
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine A monitoring by radioimmunoassay (RIA) and high-performance liquid chromatography (HPLC) after liver transplantation: influence of route of administration and of liver function on the RIA:HPLC ratio.
    Oldhafer KJ; Schumann G; Wonigeit K; Oellerich M; Ringe B; Pichlmayr R
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):361-5. PubMed ID: 3291268
    [No Abstract]   [Full Text] [Related]  

  • 12. Ciclosporin metabolite pattern in blood and urine of liver graft recipients. II. Influence of cholestasis and rejection.
    Christians U; Kohlhaw K; Budniak J; Bleck JS; Schottmann R; Schlitt HJ; Almeida VM; Deters M; Wonigeit K; Pichlmayr R
    Eur J Clin Pharmacol; 1991; 41(4):291-6. PubMed ID: 1804641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine metabolite pattern in blood from patients with acute GVHD after BMT.
    Christians U; Spiekermann K; Bader A; Schottmann R; Linck A; Wonigeit K; Sewing KF; Link H
    Bone Marrow Transplant; 1993 Jul; 12(1):27-33. PubMed ID: 8374534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measuring cyclosporin in immunosuppressive treatment following liver and heart transplantation].
    Hamilton G; Roth E; Mühlbacher F; Funovics J; Piza F; Schindler J; Woloszcuk W; Havel M; Laczkovics A
    Wien Klin Wochenschr; 1986 Dec; 98(24):820-4. PubMed ID: 3548080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine blood concentrations determined by different assay methods in heart transplant patients.
    Zylber-Katz E; Granit L
    Ther Drug Monit; 1989 Sep; 11(5):592-7. PubMed ID: 2815235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary lipid composition after liver transplantation: effect of allograft function and cyclosporine.
    Ko CW; Kowdley KV; Haigh WG; Lee SP
    Liver Transpl Surg; 1998 Jul; 4(4):258-64. PubMed ID: 9649637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver function.
    Bleck JS; Schlitt HJ; Christians U; Schottmann R; Thiesemann C; Strohmeyer S; Kohlhaw K; Wonigeit K; Pichlmayr R; Sewing KF
    Eur J Clin Pharmacol; 1991; 40(6):565-9. PubMed ID: 1679393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies.
    Rosano TG; Pell MA; Freed BM; Dybas MT; Lempert N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):330-8. PubMed ID: 3284076
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring cyclosporine in liver-transplant recipients: effects of clinical status on the performance of two monoclonal antibody-based methods.
    Tredger JM; Gonde CE; Williams R
    Clin Chem; 1992 Jan; 38(1):108-13. PubMed ID: 1733580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of HPLC and conventional bilirubin measurements in the detection of early cholestasis.
    Pieper-Bigelow C; Eckfeldt J; Levitt MD
    J Lab Clin Med; 1995 May; 125(5):654-61. PubMed ID: 7738430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.